DUBLIN–(BUSINESS WIRE)–The “Antibody Contract Development & Manufacturing Organization Market Forecast to 2033” has been added to ResearchAndMarkets.com’s offering. The global antibody contract development and manufacturing organization (CDMO) market is poised for substantial growth, with its value estimated at USD 21.1 billion in 2024 and projected to soar to USD 45.8 billion by 2033. This represents a CAGR of 9.38% from 2025 to 2033, driven by a surge in demand for monoclonal antibodies